Endometrial cancer remains a major gynecological malignancy with a rising incidence and limited treatment options for advanced cases. Our previous study demonstrated that the Q7 anticancer peptide ...
Modular nanorobot from University of Basel cut cancer cell viability to 16% by synthesizing drugs directly on cell surfaces ...
Re-VOLVE: Phase II clinical trial in women with ovarian cancer progressing post-PARP inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. Circulating tumor DNA ...
A team at the University of Basel, Switzerland, has developed a versatile nanorobot with propulsion and payload modules. The ...
MSCs possess tumor-homing abilities and exhibit low immunogenicity. MSCs can be engineered to deliver therapeutic agents, such as proteins, microRNAs, and drugs, directly to the tumor microenvironment ...
Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor ...
Scientists at the University of Pennsylvania have shown for the first time that it’s possible to detect dormant cancer cells in breast cancer survivors and eliminate them with repurposed drugs, ...
Liposuction and plastic surgery aren’t often mentioned in the same breath as cancer. But they are the inspiration for a new approach to treating cancer that uses engineered fat cells to deprive tumors ...
A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...
A cell is fundamentally a container—a vessel that encapsulates life at the most basic level. Many biologists believe encapsulation of chemicals may have been necessary for evolution to gain traction.